Search results for "Heart Failure"
Frailer heart failure patients less likely to receive guideline-recommended therapy
A prospective analysis of patients with heart failure and reduced ejection fraction in Japan found that the proportion receiving angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, beta-blockers, and mineralocorticoid receptor antagonists decreased as physical frailty increased.
https://acpinternist.org/weekly/archives/2023/06/20/4.htm
20 Jun 2023
Marking achievements in gender equity
The President-elect of the American Medical Women's Association discusses mentorship, advocacy, and more.
https://acpinternist.org/archives/2023/09/marking-achievements-in-gender-equity.htm
1 Sep 2023
Adherence to sleep apnea treatment reduces health care use, costs in heart failure
Positive airway pressure-adherent patients with heart failure with preserved ejection fraction and obstructive sleep apnea had fewer health care visits, including ED and hospital visits, than nonadherent patients, according to a new industry-funded study.
https://acpinternist.org/weekly/archives/2023/07/18/2.htm
18 Jul 2023
Quadruple therapy for heart failure cost-effective compared to previous standard of care
Adding a sodium-glucose cotransporter-2 inhibitor to standard care had intermediate cost-effectiveness, but replacing an angiotensin-converting enzyme inhibitor with an angiotensin receptor-neprilysin inhibitor was only borderline cost-effective, a modeling study found.
https://acpinternist.org/weekly/archives/2023/06/13/1.htm
13 Jun 2023
Work toward equity in Black men's health
An expert discusses causes and effects of health disparities as well as ways to incorporate health equity into the practice of medicine.
https://acpinternist.org/archives/2023/07/work-toward-equity-in-black-mens-health.htm
1 Jul 2023
Meta-analysis compares mortality benefits of heart failure treatment combinations
Patients taking an angiotensin receptor-neprilysin inhibitor, beta-blocker, mineralocorticoid receptor antagonist, and sodium-glucose cotransporter-2 inhibitor showed the greatest reduction in risk of death, the analysis of heart failure with reduced ejection fraction found.
https://acpinternist.org/weekly/archives/2021/12/14/4.htm
14 Dec 2021
Useful physical exam skills for inpatient assessment
This month's expert discusses measuring vital signs, orthostatic hypotension, and the cardiac exam in the context of inpatient care.
https://acpinternist.org/archives/2023/07/useful-physical-exam-skills-for-inpatient-assessment.htm
1 Jul 2023
ED, outpatient visits for worsening heart failure on the rise since 2010
A cohort study that analyzed encounters in one health system for worsening heart failure found that ED and observation stays and outpatient visits account for approximately half of the visits, with hospitalizations comprising the other half.
https://acpinternist.org/weekly/archives/2022/07/05/5.htm
5 Jul 2022
Collaboration with heart failure patients key
Comanaging cardiology patients after heart failure requires small adjustments, following recent guidelines, and patient involvement in decisions.
https://acpinternist.org/archives/2021/07/collaboration-with-heart-failure-patients-key.htm
1 Jul 2021
Cardiac societies issue new joint guideline on management of heart failure
The updated guideline recommends sodium-glucose cotransporter-2 inhibitors for many heart failure patients, regardless of their diabetes status, among other changes.
https://acpinternist.org/weekly/archives/2022/04/05/2.htm
5 Apr 2022